Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH)

被引：0

作者：

Qiang Liu

Yunkai Zhu

Jianping Liu

Jun Qi

Jian Kang

机构：

[1] Shanghai Jiao Tong University School of Medicine,Department of Urology, Xinhua Hospital

[2] Shanghai Jiao Tong University School of Medicine,Department of Ultrasonography, Xinhua Hospital

[3] Nantong Rich Hospital,Department of Radiology

来源：

International Urology and Nephrology | 2017年 / 49卷

关键词：

Intravesical prostatic protrusion; International Prostatic Symptom Score; Benign prostatic hyperplasia; Ultrasound; Urodynamics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：399 / 404

页数：5

共 50 条

[41] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
A J Gross
M Busse
J Leonard
H Schumacher
Prostate Cancer and Prostatic Diseases, 2005, 8 : 210 - 214
[42] Doxazosin gastrointestinal therapeutic system (GITS) versus standard doxazosin in patients with symptomatic benign prostatic hyperplasia (BPH): Results of a study in Scandinavia.
Andersen, M
Dahlstrand, C
Hoye, K
Bendiksen, F
Puente, J
JOURNAL OF UROLOGY, 1998, 159 (05): : 256 - 256
[43] Evaluation of male sexual function in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon®), Tamsulosin or Finasteride
Zlotta, AR
Teillac, P
Raynaud, JP
Schulman, CC
EUROPEAN UROLOGY, 2005, 48 (02) : 269 - 276
[44] Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression
Berges, R
EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 19 - 24
[45] Correlation between intravesical prostatic protrusion, prostate volume, age, and degree of LUTS with the succes rate of Trial Voiding Without Catheter (TWOC) in patients with benign prostate hyperplasia
Ferdian, V.
Tjahjodjati, T.
BJU INTERNATIONAL, 2016, 117 : 14 - 14
[46] Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 MI or greater
Kaplan, SA
McConnell, JD
Roehrborn, CG
Meehan, AG
Lee, MW
Noble, WR
Kusek, JW
Nyberg, LM
JOURNAL OF UROLOGY, 2006, 175 (01): : 217 - 220
[47] Changes in lower urinary tract symptoms (LUTS) in men receiving medical therapy for benign prostatic hyperplasia (BPH): Longitudinal outcomes from the BPH registry
Wei, John T.
Miner, Martin
Roehrbom, Claus G.
Rosen, Raymond C.
Seftel, Allen D.
JOURNAL OF UROLOGY, 2008, 179 (04): : 524 - 524
[48] The superior beneficial effect of combination therapy with doxazosin and finasteride versus either drug alone on clinical progression of benign prostatic hyperplasia in the MTOPS trial was not dependent on patients having prostatic enlargement at baseline
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 213 - 213
[49] Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia.
Botto, H
Lan, O
Poulain, JE
Comenducci, A
PROGRES EN UROLOGIE, 2005, 15 (06): : 1090 - 1095
[50] Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
Basiri, Abbas
Zare, Rasool
Zahir, Mazyar
Kashi, Amir Hossein
Zobeiry, Mahsa
Borumandnia, Nasrin
Abedi, Amir Reza
Golshan, Shabnam
AFRICAN JOURNAL OF UROLOGY, 2024, 30 (01)

← 1 2 3 4 5 →